Observational studyPloS one2026

Early potential safety signals for gliptins and gliflozins using real-world pharmacy data compared to spontaneous reporting.

Maria-Isabel Jimenez-Serrania et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.